Anixa Biosciences, Inc.

ANIX · NASDAQ
Analyze with AI
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Operating Activities
Net Income-$13-$10-$14-$13
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$4$6$8
Change in WC$1-$1$0$0
Other Non-Cash$0$0$1-$0
Operating Cash Flow-$7-$6-$6-$5
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$64-$44-$22-$16
Inv. Sales/Matur.$68$39$12$13
Other Inv. Act.$0$0-$11$0
Investing Cash Flow$4-$6-$11-$4
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$3$0$0$31
Stock Repurch.-$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$3$0$0$32
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$11-$17$23
Supplemental Information
Beg. Cash$1$12$29$6
End Cash$1$1$12$29
Free Cash Flow-$7-$6-$6-$5
Anixa Biosciences, Inc. (ANIX) Financial Statements & Key Stats | AlphaPilot